|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 123.8 USD | -4.64% |
|
-4.53% | +13.56% |
| 06-28 | Merck: positive opinion for Winrevair in Europe | CF |
| 06-28 | Merck Gets CHMP Backing of Winrevair in Pulmonary Arterial Hypertension | DJ |
BEIJING, June 25 (Reuters) - China's National Drug Administration has granted Merck's KEYTRUDA therapy a license for first-line treatment of certain stomach cancer patients in the country.
Merck is known as MSD outside the United States and Canada. (Reporting by Beijing newsroom Editing by David Goodman )
| 1st Jan change | Capi. | |
|---|---|---|
| +13.56% | 329B | |
| +55.32% | 819B | |
| -6.75% | 351B | |
| +10.68% | 298B | |
| +16.57% | 242B | |
| +2.04% | 225B | |
| +13.31% | 217B | |
| +8.48% | 168B | |
| -2.81% | 158B | |
| +0.20% | 120B |
MERCK & CO., INC. 
